SAT0263 Predictors of remission maintenance and successful therapy discontinuation in patients with non-radiographic axial spondyloarthritis (NR-AXSPA) who achieved sustained remission on open-label adalimumab (ADA) treatment
Sieper, J., Landewé, R., Magrey, M., Anderson, J., Zhong, S., Wang, X., Lertratanakul, A.
Published in Annals of the rheumatic diseases (01.06.2018)
Published in Annals of the rheumatic diseases (01.06.2018)
Get full text
Journal Article
OP0026 Adalimumab serum concentration fails to predict achievement of sustained remission or absence of flare for patients with non-radiographic axial spondyloarthritis in the ability-3 study
Kwatra, N.V., Magrey, M., Mease, P.J., Sieper, J., Landewe, R., Wang, X., Lertratanakul, A., Anderson, J.K., Mostafa, N.M.
Published in Annals of the rheumatic diseases (01.06.2018)
Published in Annals of the rheumatic diseases (01.06.2018)
Get full text
Journal Article
Prospective assessment of C4d deposits on circulating cells and renal tissues in lupus nephritis: a pilot study
Batal, I, Liang, K, Bastacky, S, Kiss, LP, McHale, T, Wilson, NL, Paul, B, Lertratanakul, A, Ahearn, JM, Manzi, SM, Kao, AH
Published in Lupus (01.01.2012)
Published in Lupus (01.01.2012)
Get full text
Journal Article
POS0407 PROTEOMICS ANALYSIS COMPARING THE MODE OF ACTION OF UPADACITINIB BETWEEN NON-BIOLOGIC-DMARD-IR AND BIOLOGIC-DMARD-IR PsA PATIENTS IDENTIFIES DISTINCT PATHOGENIC PATHWAYS IN THE SELECT-PsA 1 AND SELECT-PsA 2 PHASE 3 STUDIES
Sornasse, T., Anderson, J., Kato, K., Lertratanakul, A., McInnes, I., Ritchlin, C. T.
Published in Annals of the rheumatic diseases (01.06.2021)
Published in Annals of the rheumatic diseases (01.06.2021)
Get full text
Journal Article
OP0030 TREATMENT OF NON-BIOLOGIC-DMARD-IR PSA PATIENTS WITH UPADACITINIB OR ADALIMUMAB RESULTS IN THE MODULATION OF DISTINCT FUNCTIONAL PATHWAYS: PROTEOMICS ANALYSIS OF THE SELECT-PSA 1 PHASE 3 STUDY
Sornasse, T., Anderson, J., Kato, K., Lertratanakul, A., Ritchlin, C. T., McInnes, I.
Published in Annals of the rheumatic diseases (01.06.2021)
Published in Annals of the rheumatic diseases (01.06.2021)
Get full text
Journal Article
AB0889 Association Between Clinically Meaningful Improvements in Patient-Reported Outcomes and Stringent Measures of Disease Activity in Patients With Psoriatic Arthritis Treated With Upadacitinib Versus Placebo or Adalimumab: Results From a Phase 3 Trial
Gossec, L., Damjanov, N., Tsuji, S., Lertratanakul, A., Lippe, R., Patel, J., Zueger, P., De Vlam, K.
Published in Annals of the rheumatic diseases (01.06.2022)
Published in Annals of the rheumatic diseases (01.06.2022)
Get full text
Journal Article
POS1026 PREDICTORS FOR ACHIEVEMENT OF LOW DISEASE ACTIVITY AT WEEK 56 IN PATIENTS WITH PSORIATIC ARTHRITIS WHO RECEIVED UPADACITINIB 15 MG ONCE DAILY: POOLED ANALYSIS OF TWO PHASE 3 STUDIES
Aletaha, D., Mease, P. J., Lippe, R., Behrens, F., Haaland, D., Palominos, P., Lertratanakul, A., Lane, M., Douglas, K., Nash, P., Kavanaugh, A.
Published in Annals of the rheumatic diseases (01.06.2022)
Published in Annals of the rheumatic diseases (01.06.2022)
Get full text
Journal Article
POS0934 EFFICACY OF UPADACITINIB ON PSORIATIC ARTHRITIS WITH AXIAL INVOLVEMENT DEFINED BY INVESTIGATOR ASSESSMENT AND PRO-BASED CRITERIA: RESULTS FROM TWO PHASE 3 STUDIES
Baraliakos, X., Ranza, R., Ostor, A., Ciccia, F., Coates, L., Rednic, S., Walsh, J. A., Gao, T., Lertratanakul, A., Song, I. H., Ganz, F., Douglas, K., Deodhar, A.
Published in Annals of the rheumatic diseases (01.06.2022)
Published in Annals of the rheumatic diseases (01.06.2022)
Get full text
Journal Article
POS1032 EFFICACY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS STRATIFIED BY NUMBER OF PRIOR BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS
Mease, P. J., Lertratanakul, A., Strober, B., Tsuji, S., Richette, P., Lovan, C., Feng, D., Anderson, J., Van den Bosch, F.
Published in Annals of the rheumatic diseases (01.06.2021)
Published in Annals of the rheumatic diseases (01.06.2021)
Get full text
Journal Article
AB0547 ASSOCIATION BETWEEN ACHIEVEMENT OF LOW DISEASE ACTIVITY OR REMISSION WITH IMPROVEMENT IN QUALITY OF LIFE IN UPADACITINIB-TREATED PATIENTS IN THE PHASE 3 SELECT-PsA 1 AND 2 STUDIES
Kavanaugh, A., Mease, P. J., Douglas, K., Behrens, F., Haaland, D., Palominos, P., Lertratanakul, A., Lane, M., Lippe, R., Aletaha, D., Nash, P.
Published in Annals of the rheumatic diseases (01.06.2021)
Published in Annals of the rheumatic diseases (01.06.2021)
Get full text
Journal Article
AB0529 CHARACTERIZATION OF REMISSION IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH UPADACITINIB: POST-HOC ANALYSIS FROM TWO PHASE 3 TRIALS
Mease, P. J., Kavanaugh, A., Gladman, D. D., Fitzgerald, O., Soriano, E., Nash, P., Feng, D., Lertratanakul, A., Douglas, K., Lippe, R., Gossec, L.
Published in Annals of the rheumatic diseases (01.06.2021)
Published in Annals of the rheumatic diseases (01.06.2021)
Get full text
Journal Article
POS0235 COMPARISON OF AXIAL AND PERIPHERAL MANIFESTATIONS IN PATIENTS WITH PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS IN UPADACITINIB CLINICAL TRIALS
Baraliakos, X., Deodhar, A., Ranza, R., Rednic, S., Ciccia, F., Ganz, F., Gao, T., Lertratanakul, A., Song, I. H., Ostor, A., Coates, L. C.
Published in Annals of the rheumatic diseases (01.06.2021)
Published in Annals of the rheumatic diseases (01.06.2021)
Get full text
Journal Article
AB0522 SAFETY PROFILE OF UPADACITINIB UP TO 3 YEARS IN PATIENTS WITH PSORIATIC ARTHRITIS: AN INTEGRATED ANALYSIS FROM THE PHASE 3 PROGRAM
Burmester, G. R., Winthrop, K., Blanco, R., Nash, P., Goupille, P., Azevedo, V. F., Salvarani, C., Rubbert-Roth, A., Lesser, E., Mccaskill, R., Liu, J., Pierre-Louis, B., Walko, S., Lippe, R., Lertratanakul, A., Ruderman, E.
Published in Annals of the rheumatic diseases (01.06.2021)
Published in Annals of the rheumatic diseases (01.06.2021)
Get full text
Journal Article
POS0196 UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS REFRACTORY TO BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS: 56-WEEK DATA FROM THE PHASE 3 SELECT-PSA 2 STUDY
Mease, P. J., Lertratanakul, A., Papp, K., Van den Bosch, F., Tsuji, S., Dokoupilova, E., Keiserman, M., Bu, X., Chen, L., Mccaskill, R., Zueger, P., Mcdearmon-Blondell, E., Pangan, A., Tillett, W.
Published in Annals of the rheumatic diseases (01.06.2021)
Published in Annals of the rheumatic diseases (01.06.2021)
Get full text
Journal Article
AB0550 EFFICACY OF UPADACITINIB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND A LOW OR HIGH SWOLLEN JOINT COUNT: A SUBGROUP ANALYSIS OF 2 PHASE 3 STUDIES (SELECT-PsA 1 AND SELECT-PsA 2)
Gossec, L., Gladman, D. D., Mcdearmon-Blondell, E., Sewerin, P., Ritchlin, C. T., Feng, D., Lertratanakul, A., Ranza, R., Tam, L. S., Marchesoni, A., Coates, L. C., Nash, P.
Published in Annals of the rheumatic diseases (01.06.2021)
Published in Annals of the rheumatic diseases (01.06.2021)
Get full text
Journal Article
OP0243 Predictors of remission at week 12 in patients with non-radiographic axial spondyloarthritis receiving open-label adalimumab treatment in the ability-3 study
Sieper, J, Landewé, R, Magrey, M, Anderson, JK, Zhong, S, Wang, X, Lertratanakul, A
Published in Annals of the rheumatic diseases (01.06.2017)
Published in Annals of the rheumatic diseases (01.06.2017)
Get full text
Journal Article
OP0223 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND INADEQUATE RESPONSE TO BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (SELECT-PSA-2): A DOUBLE-BLIND, RANDOMIZED CONTROLLED PHASE 3 TRIAL
Genovese, M. C., Lertratanakul, A., Anderson, J., Papp, K., Tillett, W., Van den Bosch, F., Tsuji, S., Dokoupilova, E., Keiserman, M., Wang, X., Zhong, S., Zueger, P., Pangan, A., Mease, P. J.
Published in Annals of the rheumatic diseases (01.06.2020)
Published in Annals of the rheumatic diseases (01.06.2020)
Get full text
Journal Article
25‐Hydroxyvitamin D and Cardiovascular Disease in Patients With Systemic Lupus Erythematosus: Data From a Large International Inception Cohort
Lertratanakul, Apinya, Wu, Peggy, Dyer, Alan, Urowitz, Murray, Gladman, Dafna, Fortin, Paul, Bae, Sang‐Cheol, Gordon, Caroline, Clarke, Ann, Bernatsky, Sasha, Hanly, John G., Isenberg, David, Rahman, Anisur, Merrill, Joan, Wallace, Daniel J., Ginzler, Ellen, Khamashta, Munther, Bruce, Ian, Nived, Ola, Sturfelt, Gunnar, Steinsson, Kristjan, Manzi, Susan, Dooley, Mary Anne, Kalunian, Kenneth, Petri, Michelle, Aranow, Cynthia, Font, Josep, Vollenhoven, Ronald, Stoll, Thomas, Ramsey‐Goldman, Rosalind
Published in Arthritis care & research (2010) (01.08.2014)
Published in Arthritis care & research (2010) (01.08.2014)
Get full text
Journal Article
Corrélation entre amélioration des résultats rapportés par le patient (PRO) et mesures strictes de l’activité de la maladie chez des patients atteints de rhumatisme psoriasique et traités par upadacitinib versus placebo ou adalimumab
Gossec, L., Damjanov, N., Tsuji, S., Lertratanakul, A., Lippe, R., Patel, J., Zueger, P., De Vlam, K.
Published in Revue du rhumatisme (Ed. française : 1993) (01.12.2021)
Published in Revue du rhumatisme (Ed. française : 1993) (01.12.2021)
Get full text
Journal Article